Cryo-Save

1. Investing for the future
2. Growing markets
3. Sustaining market position

Cryo-Save the market leader in
family stem cell storage internationally

1. Investing for the future

Cryo-Save is profitable, cash-generative and pays a dividend. It has been profitable since 2005 and expects to be able to increase its profitability, driven by revenue growth and its highly operationally leveraged business model.

The Group has maintained its leading market position in all key markets and continues to achieve its strategic objectives: organic growth in existing markets, geographic growth into new markets such as Asia, North Africa, North and South America, growth by acquisition and development of new services.

2. Growing markets

Cryo-Save is well positioned to benefit from the expanding market for stem cell storage, driven by the increasing number and the successful use of stored samples in therapies, and in clinical studies and trials.

3. Sustaining market position

Thanks to Cryo-Save’s in-house expertise, high quality standards, extensive regulatory experience and collaborations with academia and support of scientific innovation, it has strengthened its leadership. As a leading international brand, Cryo-Save is able to leverage its state-of-the-art processing and storage facilities along with its strong track record in the logistics of collecting and releasing samples to compete effectively and strengthen its position in the market.